Combination Therapy With Fludarabine, Mitoxantrone and Rituximab in Mantle Cell Lymphoma
Clinical trial NCT00183989 · TERMINATED
Trial details
- NCT number
- NCT00183989
- Sponsor
- University of Southern California
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2000-08-01
- Primary completion
- 2006-12-01
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.